Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses.
about
Valvular heart disease in pregnancyEfficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis.Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillationA protocol for the use of enoxaparin during pregnancy: results from 85 pregnancies including 13 multiple gestation pregnanciesAnticoagulant therapy of pregnant patients with prosthetic heart valves: rationale for a clinical trial of low molecular weight heparin.Outcome of pregnancy in women with mechanical valves.Outcome of pregnancy in women with congenital heart disease.Anti-coagulation during pregnancy in women with mechanical heart valves: a prospective studyManagement of pregnancy in patients with congenital heart disease.Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis.Pregnancy complicated by valvular heart disease: an update.Anticoagulation in pregnant women with mechanical heart valve prostheses.Anticoagulation in pregnant women with prosthetic heart valves.Pregnancy outcome after mechanical mitral valve replacement: a prospective study.Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves.Challenges in managing anticoagulant therapy in patients with heart valve prostheses.Cardiac risks and management of complications in pregnant women with congenital heart disease.Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: a meta-analysis.Pregnancy Outcome in Women with Mechanical Prosthetic Heart Valves Treated with Unfractionated Heparin (UFH) or Enoxaparin.Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.Delayed presentation of low molecular weight heparin treatment failure in a patient with mitral valve prosthesis.Prosthetic valve thrombosis presenting as an acute embolic myocardial infarction in a pregnant patient: issues on anticoagulation regimens and thrombolytic therapy.A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves.Effect of oral anticoagulant during pregnancy with prosthetic heart valve.Anticoagulation in patients with mechanical valves during pregnancy.Anticoagulation in pregnancy with mechanical heart valves: 10-year experience.Anticoagulation for prosthetic heart valves in pregnancy. Is there an answer?Tinzaparin failure in a pregnant patient with a mitral metal valve.Low molecular weight heparins: a developmental perspective.Valvular heart disease and pregnancy part II: management of prosthetic valves.Mechanical valves and pregnancy: a caveat.
P2860
Q26746741-C0BF7D55-F1BB-438A-91E3-F3CBD45D0F27Q27690881-CE09DE27-2004-4FE3-81F1-253770DCFB75Q28167261-E4D88BF9-2277-4204-B376-16B044356CA5Q28173997-5B25E7D6-7B8F-4763-B5C8-F252F631576DQ33331821-5B3AAF4C-3C49-49B2-B5B2-DF78D280D74AQ33580417-FC985EE8-E634-4460-A8E4-8369281AED83Q33633361-A7D6308F-A094-484B-95AA-481E56DE14CAQ33692939-9022376F-123B-465D-8CD9-2A21A5A6C062Q34644202-EE1700D8-FC24-4564-8A2E-3802A33159EFQ34811304-7B55C374-99A5-4067-A2D6-B2477A05C084Q35021794-88C95979-3AE2-443F-9D14-9C1B8B86B3E3Q35372733-7A472C17-96F3-42BC-BED4-3CA60DBC585FQ35862159-D2277810-32C1-40BF-BC1C-469A9A0B5899Q36472540-5EFB3530-9D51-43FC-9F6C-8FA7794743ECQ36590932-265648EB-9D1F-462A-8A85-5B9700BD796EQ36815991-C9FFB474-2CBF-4932-A471-9D93F19F3802Q37993154-9C4E507D-03D5-4D13-B075-4CF7E37C0CA6Q38193314-90E73EF8-658D-42DB-AEA1-16CA1296ADEFQ41651180-CE2304FD-5E58-4AAB-9B5C-AF3D002C1E9EQ41690367-FF01AF20-1314-4DA5-9772-83554D7C84C2Q44926334-84BE6B03-0EDB-405B-992F-6EED878A68DDQ46043176-D299C679-F180-4002-A491-E2BD0D31E345Q46330852-A9E1EF19-A3B3-4C46-A7DF-52CE85FDC4D1Q46349832-8DF93F23-6517-4DD5-9147-0618A5D85D36Q46406358-4CBE9946-C559-4331-B0DF-BB117D73D683Q46879269-0D8E5784-E4C3-49FF-BEC3-FBFEC6D63629Q46879273-B5ED2261-E0D7-4EE4-BBAC-EC7D6A52F7C1Q47300914-95A7E3EE-35C9-4B8F-83D1-53AA82D0AC17Q47306934-BB2D33A9-4BD9-4F66-BFA0-5446A882BA99Q47546619-6DD3F9F2-CDC6-42A0-B363-7DA7EE84844CQ51197157-957D2003-1F87-4AEE-BB17-C06D6E016F7D
P2860
Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@ast
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@en
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@nl
type
label
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@ast
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@en
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@nl
prefLabel
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@ast
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@en
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@nl
P2093
P1476
Failure of adjusted doses of s ...... ical cardiac valve prostheses.
@en
P2093
Izaguirre R
Mutchinick O
P304
P356
10.1016/0735-1097(96)00072-1
P407
P577
1996-06-01T00:00:00Z